New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 7, 2014
16:50 EDTHPTXHyperion Therapeutics reports Q2 adjusted EPS 98c
Reports Q2 revenue $37.1M.
News For HPTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2015
09:12 EDTHPTXHyperion Therapeutics has reached attractive entry point, says Roth Capital
Roth Capital believes that Hyperion is back in favor with investors, given the 11% increase in its stock so far this year. However, the firm notes that the company's valuation is still below the average of its peer group. Roth thinks the company has a number of near-term positive catalysts, and it keeps a Buy rating on the shares.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use